Tempus AI, Inc

Lucratividade por seis meses: +83.12%
Rendimento de dividendos: 0%

73.78 $

0 $ 0%
31.83 $
89.44 $

Min./max. por um ano

Cronograma de promoção Tempus AI, Inc

Os principais parâmetros

A moeda do relatório
usd
Indústria
Life Sciences Tools & Services
Isin
US88023B1035
Moeda
usd
Setor
Health Care
Site
Tempo de IPO
2024-06-14

Nota

Subestimação
Nome Significado Nota
P/S 5.84 2
P/BV 71.82 1
P/E -12.53 0
Eficiência
Nome Significado Nota
ROA -94.73 0
ROE 106.47 10
ROIC 0 0
Dividendos
Nome Significado Nota
Rendimento de dividendos 0 0
DSI 0 0
O crescimento médio de dividendos 0 0
Obrigação
Nome Significado Nota
Debt/EBITDA -0.7668 10
Debt/Ratio 0.5054 9
Debt/Equity 8.31 0
Pulso de crescimento
Nome Significado Nota
Receita, bilhão, % 268.83 10
Ebitda, % 257.22 10
EPS, % 362.58 10

Preços

Preço Min. Máx. Mudar Mudanças na indústria Mudanças no índice
Ontem 73.78 $ 0 $ 0 $ 0 % 0 % 0 %
Semana 66.34 $ 60.82 $ 73.78 $ +11.21 % 0 % 0 %
Mês 64.49 $ 54.89 $ 73.78 $ +14.41 % 0 % 0 %
3 meses 71.28 $ 53.2 $ 73.78 $ +3.51 % 0 % 0 %
Seis meses 40.29 $ 37.23 $ 85.71 $ +83.12 % 0 % 0 %
Ano 52.48 $ 31.83 $ 89.44 $ +40.59 % 0 % 0 %
3 anos 24.96 $ 24.96 $ 89.44 $ +278.97 % 0 % 0 %
5 anos 24.96 $ 24.96 $ 89.44 $ +278.97 % 0 % 0 %
10 anos 24.96 $ 24.96 $ 89.44 $ +278.97 % 0 % 0 %
No acumulado do ano 48.86 $ 31.83 $ 89.44 $ +51 % 0 % 0 %

A administração da empresa

Supervisor Cargo Pagamento Ano de nascimento
Mr. Eric P. Lefkofsky Co-Founder, CEO, President & Chairman 1970 (55 anos)
Mr. James Rogers Chief Financial Officer 1986 (39 anos)
Mr. Ryan Fukushima Chief Operating Officer 1985 (40 anos)
Mr. Ryan M. Bartolucci Chief Accounting Officer 1982 (43 anos)
Mr. Shane Colley Chief Technology Officer
Dr. Kate A. Sasser Ph.D. Chief Scientific Officer 1977 (48 anos)
Mr. Erik Phelps Executive VP, Assistant Secretary and Chief Administrative & Legal Officer 1971 (54 anos)
Ms. Patty Spiller Senior Vice President of Marketing
Ms. Christina Antoniou Senior VP & Head of Corporate Development
Ms. Stacey Kraft Chief People Officer

Informações sobre a empresa

Endereço: United States, Chicago, 600 West Chicago Avenue - Abrir no google cards, Abra os cartões yandex
Site: https://www.tempus.com

Sobre a empresa Tempus AI, Inc

Tempus AI, Inc operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company also offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company has a collaboration with united therapeutics to study use of AI to detect patients at risk for pulmonary hypertension. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc in January 2023. Tempus AI, Inc was incorporated in 2015 and is headquartered in Chicago, Illinois.